Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Blackowicz

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Critical Care Explorations|August 28, 2023
Economic Analysis of Renal Replacement Therapy Modality in Acute Kidney Injury Patients With Fluid OverloadOlivier Ethgen, Raghavan Murugan, Jorge Echeverri, et al.
Neuro-Oncology Practice|March 9, 2026
Patient and caregiver experiences with selumetinib for the treatment of pediatric patients with neurofibromatosis type 1 and plexiform neurofibromasJulia Meade, Michael Blackowicz, Ayo Adeyemi, et al.
Neurology|October 8, 2024
Socioeconomic Factors Associated with ≥2-year Delayed Diagnosis of Neuromyelitis Optica Spectrum Disorder (NMOSD) in the United StatesMichael Blackowicz, Josin James, Kelly McNeil-Posey, et al.
Environmental Research|January 11, 2017
Perfluoroalkyl substances and fish consumptionKrista Y Christensen, Michelle Raymond, Michael Blackowicz, et al.
Journal of Affective Disorders|December 2, 2020
Meaningful Change in Depression Symptoms Assessed with the Patient Health Questionnaire (PHQ-9) and Montgomery-Åsberg Depression Rating Scale (MADRS) Among Patients with Treatment Resistant Depression in Two, Randomized, Double-blind, Active-controlled Trials of Esketamine Nasal Spray Combined With a New Oral AntidepressantStacie Hudgens, Lysbeth Floden, Michael Blackowicz, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Critical Care Explorations|August 28, 2023
Economic Analysis of Renal Replacement Therapy Modality in Acute Kidney Injury Patients With Fluid OverloadOlivier Ethgen, Raghavan Murugan, Jorge Echeverri, et al.
Neuro-Oncology Practice|March 9, 2026
Patient and caregiver experiences with selumetinib for the treatment of pediatric patients with neurofibromatosis type 1 and plexiform neurofibromasJulia Meade, Michael Blackowicz, Ayo Adeyemi, et al.
Neurology|October 8, 2024
Socioeconomic Factors Associated with ≥2-year Delayed Diagnosis of Neuromyelitis Optica Spectrum Disorder (NMOSD) in the United StatesMichael Blackowicz, Josin James, Kelly McNeil-Posey, et al.
Environmental Research|January 11, 2017
Perfluoroalkyl substances and fish consumptionKrista Y Christensen, Michelle Raymond, Michael Blackowicz, et al.
Journal of Affective Disorders|December 2, 2020
Meaningful Change in Depression Symptoms Assessed with the Patient Health Questionnaire (PHQ-9) and Montgomery-Åsberg Depression Rating Scale (MADRS) Among Patients with Treatment Resistant Depression in Two, Randomized, Double-blind, Active-controlled Trials of Esketamine Nasal Spray Combined With a New Oral AntidepressantStacie Hudgens, Lysbeth Floden, Michael Blackowicz, et al.
Pageof 1